Item 2.02Results of Operations and Financial Condition.
On
The Financial Information contained in Item 2.02 of this Report and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such filing
Item 7.01Regulation FD Disclosure.
The Company intends to participate in the 40th Annual
The information contained in Item 7.01 of this Report and Exhibit 99.2 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 8.01Other Events.
On
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit Number Description 99.1 Press release, datedJanuary 10, 2022 99.2 Presentation ofOrchard Therapeutics plc 104 Cover page interactive data file (embedded within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source